BIGGBEAUTY LTD

Company number 14156404 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BIGGBEAUTY LTD - Analysis Report

Company Number: 14156404

Analysis Date: 2025-07-29 20:20 UTC

Financial Health Assessment of BIGGBEAUTY LTD (as of 30 June 2024)


1. Financial Health Score: C

Explanation:
BIGGBEAUTY LTD shows signs of moderate financial stability with positive net current assets and growing total assets. However, the very low net assets relative to liabilities and the significant long-term creditors suggest caution. The company is not in distress but is showing symptoms of financial strain that require monitoring and management action.


2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Fixed Assets 13,342 Increased fixed assets indicate investment in long-term resources, a positive growth sign.
Current Assets 258,923 Healthy current assets, more than tripled from prior year, showing improved short-term resources.
Current Liabilities 188,576 Current liabilities have more than doubled, indicating rising short-term obligations.
Net Current Assets 70,347 Positive working capital suggests the company can cover short-term debts, a healthy cash buffer.
Total Assets less Current Liabilities 83,689 Indicates overall asset coverage of short-term debts has improved substantially.
Creditors due after 1 year 80,388 Substantial long-term liabilities pose a risk to long-term solvency if not managed carefully.
Net Assets (Shareholders’ Funds) 3,301 Very low equity base showing limited buffer against liabilities and potential vulnerability.
Employee Count 3 (up from 2) Slight growth in staff, indicating some business expansion or operational scaling.

3. Diagnosis

BIGGBEAUTY LTD’s financial data reveals a company in early growth but with emerging financial tension:

  • Healthy Cash Flow Indicators:
    The positive net current assets (working capital) of £70,347 suggest the company currently has enough short-term resources to meet immediate obligations—akin to a patient with a stable pulse and clear breathing.

  • Symptoms of Financial Strain:
    The sharp rise in both current and long-term liabilities (creditors) signals underlying financial stress. The company’s net assets are very low (£3,301), indicating a fragile equity base. This is similar to a patient with a low blood pressure reading—while not critical, it signals vulnerability.

  • Asset Growth vs Liability Growth:
    While fixed and current assets have increased, liabilities have increased even more, especially long-term creditors rising to £80,388. This imbalance suggests potential over-reliance on debt financing and risks if revenues do not grow sufficiently.

  • Micro Entity Status:
    As a micro entity, the company benefits from reduced reporting burdens but may also lack the scale and financial reserves of larger firms, which requires prudent cash flow and debt management.


4. Recommendations

To improve financial wellness and ensure long-term viability, BIGGBEAUTY LTD should consider the following steps:

  • Strengthen Equity Base:
    Explore options for equity injection or retained earnings growth to build a stronger capital buffer. Like a patient needing more red blood cells, the company needs a stronger financial foundation to absorb shocks.

  • Manage and Reduce Liabilities:
    Develop a plan to reduce both short-term and long-term creditors through negotiation, refinancing, or accelerated payments where possible. This will improve solvency and reduce financial strain.

  • Improve Cash Flow Forecasting:
    Closely monitor cash inflows and outflows to maintain the healthy net current assets and avoid liquidity shortages. Early warning signs can prevent a cash flow crisis.

  • Operational Efficiency:
    Review operational costs and efficiency given the small workforce expansion, ensuring growth does not outpace financial capacity.

  • Strategic Growth Planning:
    Given the business operates in retail sales via internet/mail order, focus on scaling sales and margin improvements to underpin asset growth and reduce reliance on external funding.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.